Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin plus self-compassion training in borderline personality disorder
2022-003670-22Phase 2Active
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Feb 2023
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised trial in borderline personality disorder (BPD) comparing Self-compassion training + oxytocin with Self-compassion training + placebo (2 arms). Primary endpoints: Self Compassion Scale Short Form and Forms of Self-Criticism/Self-Attacking and Self-Reassuring Scale. Started Feb 2023; status: active.
02
Drugs
oxytocin
03
Conditions
borderline personality disorder (BPD)
Beyond the preview
Go deeper on 2022-003670-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-003670-22.